Published Date: 07 Jun 2023
At the American Society of Clinical Oncology (ASCO) annual meeting, which concludes on Tuesday in Chicago, new developments in the fight against a variety of cancers have been made public.
Read Full NewsOctober is Breast Cancer Awareness Month, a time to spotlight a disease that will affect hundreds of thousands of Americans this year. In the U.S., a new case of breast cancer is diagnosed about every two minutes, with more ...
Pancreatic neuroendocrine neoplasms (PNENs) are a rare form of cancer that affects hormone-producing cells in the pancreas. Although uncommon, their incidence has been rising steadily over the past few decades.
Invasive lung squamous cell carcinoma (LUSC) accounts for approximately one-quarter of all lung cancers, but therapeutic options for LUSC remain limited, primarily due to the absence of well-defined, targetable molecular ...
The American Cancer Society has released a report on occurrence and outcomes in the United States for this subtype of breast cancer. Findings show an estimated 33,600 women will be diagnosed with lobular breast cancer or ...
1.
A new mechanism of radioresistance formation demonstrated in lung adenocarcinoma
2.
An inhibitor of JAK1 exhibits "remarkable" activity in T-cell lymphoma.
3.
Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies
4.
Breast cancer surgery: Study finds overnight hospital stay not important for older patients
5.
As compared to proton therapy, proton therapy is very effective in treating esophageal cancer.
1.
New Hope for Rectal Cancer Patients: Breakthrough Drug Shows Promising Results
2.
Exploring the Latest Treatments for Essential Thrombocythemia
3.
Colon cancer: Risk factors, warning signs and treatment options
4.
Unlocking the Mystery of Hemoglobin C Trait: A Closer Look at a Rare Blood Disorder
5.
Tertiary Lymphoid Structures: Pivotal Players in Cancer Prognosis and Therapeutic Response
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Thromboprophylaxis In Medical Settings- An Update
2.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
4.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation